194 related articles for article (PubMed ID: 15563673)
1. Role of p53, apoptosis, and cell proliferation in early stage Epstein-Barr virus positive and negative gastric carcinomas.
Ishii HH; Gobe GC; Yoneyama J; Mukaide M; Ebihara Y
J Clin Pathol; 2004 Dec; 57(12):1306-11. PubMed ID: 15563673
[TBL] [Abstract][Full Text] [Related]
2. Different roles of p53 between Epstein-Barr virus-positive and -negative gastric carcinomas of matched histology.
Moritani S; Sugihara H; Kushima R; Hattori T
Virchows Arch; 2002 Apr; 440(4):367-75. PubMed ID: 11956816
[TBL] [Abstract][Full Text] [Related]
3. Cell-cycle regulators, bcl-2 and NF-kappaB in Epstein-Barr virus-positive gastric carcinomas.
Chang MS; Lee HS; Jung EJ; Kim CW; Lee BL; Kim WH
Int J Oncol; 2005 Nov; 27(5):1265-72. PubMed ID: 16211221
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus (EBV) infection and p53 protein expression in gastric carcinoma.
Szkaradkiewicz A; Majewski W; Wal M; Czyzak M; Majewski P; Bierła J; Kuch A
Virus Res; 2006 Jun; 118(1-2):115-9. PubMed ID: 16413625
[TBL] [Abstract][Full Text] [Related]
5. Cell cycle regulators, APC/beta-catenin, NF-kappaB and Epstein-Barr virus in gastric carcinomas.
Kim B; Byun SJ; Kim YA; Kim JE; Lee BL; Kim WH; Chang MS
Pathology; 2010 Jan; 42(1):58-65. PubMed ID: 20025482
[TBL] [Abstract][Full Text] [Related]
6. P16 protein abnormality in Epstein-Barr virus-associated gastric carcinomas.
Ojima H; Saito K; Yamauchi H; Yamaki E; Idetu A; Hosouchi Y; Nishida Y; Tukada K; Kato H; Kuwano H
Anticancer Res; 2006; 26(2A):933-7. PubMed ID: 16619489
[TBL] [Abstract][Full Text] [Related]
7. p53 is an indicator of tumor progression in early but not advanced gastric carcinomas.
Ishii HH; Gobe GC; Ebihara Y
Hepatogastroenterology; 2007; 54(79):2159-63. PubMed ID: 18251181
[TBL] [Abstract][Full Text] [Related]
8. Role and prognostic significance of proapoptotic proteins in Epstein-Barr virus-infected gastric carcinomas.
Chang MS; Lee HS; Jung EJ; Kim CW; Lee BL; Kim WH
Anticancer Res; 2007; 27(2):785-91. PubMed ID: 17465203
[TBL] [Abstract][Full Text] [Related]
9. Relationship between EBV infection and expression of cellular proteins c-Myc, Bcl-2, and Bax in gastric carcinomas.
Lima MA; Ferreira MV; Barros MA; Pardini MI; Ferrasi AC; Mota RM; Rabenhorst SH
Diagn Mol Pathol; 2008 Jun; 17(2):82-9. PubMed ID: 18382371
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of Epstein-Barr virus involvement in gastric carcinoma in Japan.
Koriyama C; Akiba S; Itoh T; Kijima Y; Sueyoshi K; Corvalan A; Herrera-Goepfer R; Eizuru Y
Int J Mol Med; 2002 Nov; 10(5):635-9. PubMed ID: 12373307
[TBL] [Abstract][Full Text] [Related]
11. Expression of retinoblastoma protein and P16 proteins in classic Hodgkin lymphoma: relationship with expression of p53 and presence of Epstein-Barr virus in the regulation of cell growth and death.
Kim LH; Peh SC; Poppema S
Hum Pathol; 2006 Jan; 37(1):92-100. PubMed ID: 16360421
[TBL] [Abstract][Full Text] [Related]
12. Different pattern of allelic loss in Epstein-Barr virus-positive gastric cancer with emphasis on the p53 tumor suppressor pathway.
van Rees BP; Caspers E; zur Hausen A; van den Brule A; Drillenburg P; Weterman MA; Offerhaus GJ
Am J Pathol; 2002 Oct; 161(4):1207-13. PubMed ID: 12368194
[TBL] [Abstract][Full Text] [Related]
13. Silencing and CpG island methylation of GSTP1 is rare in ordinary gastric carcinomas but common in Epstein-Barr virus-associated gastric carcinomas.
Kim J; Lee HS; Bae SI; Lee YM; Kim WH
Anticancer Res; 2005; 25(6B):4013-9. PubMed ID: 16309193
[TBL] [Abstract][Full Text] [Related]
14. EBV-positive gastric adenocarcinomas: a distinct clinicopathologic entity with a low frequency of lymph node involvement.
van Beek J; zur Hausen A; Klein Kranenbarg E; van de Velde CJ; Middeldorp JM; van den Brule AJ; Meijer CJ; Bloemena E
J Clin Oncol; 2004 Feb; 22(4):664-70. PubMed ID: 14966089
[TBL] [Abstract][Full Text] [Related]
15. [Epstein-Barr virus infection and p16(INK4a) overexpression in gastric adenocarcinoma].
Wang P; Zhang Q; Yang JF; Cheng ZN; Zhang K; Yu DH
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Aug; 22(4):244-6. PubMed ID: 19105332
[TBL] [Abstract][Full Text] [Related]
16. p53 overexpression is different in Epstein-Barr virus-associated and Epstein-Barr virus-negative carcinoma.
Leung SY; Chau KY; Yuen ST; Chu KM; Branicki FJ; Chung LP
Histopathology; 1998 Oct; 33(4):311-7. PubMed ID: 9822919
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus and microsatellite instability in gastric carcinogenesis.
Chang MS; Lee HS; Kim HS; Kim SH; Choi SI; Lee BL; Kim CW; Kim YI; Yang M; Kim WH
J Pathol; 2003 Apr; 199(4):447-52. PubMed ID: 12635135
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus association with early cancers found together with gastric medullary carcinomas demonstrating lymphoid infiltration.
Takano Y; Kato Y
J Pathol; 1995 Jan; 175(1):39-44. PubMed ID: 7891225
[TBL] [Abstract][Full Text] [Related]
19. Lymphocyte-rich gastric cancer: associations with Epstein-Barr virus, microsatellite instability, histology, and survival.
Grogg KL; Lohse CM; Pankratz VS; Halling KC; Smyrk TC
Mod Pathol; 2003 Jul; 16(7):641-51. PubMed ID: 12861059
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic characteristics of Epstein-Barr virus-incorporated gastric cancers in Korea.
Chang MS; Lee HS; Kim CW; Kim YI; Kim WH
Pathol Res Pract; 2001; 197(6):395-400. PubMed ID: 11432666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
